期刊
VETERINARY MICROBIOLOGY
卷 268, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.vetmic.2022.109425
关键词
Phage lysin; Streptococcus suis; Functional domain; Key amino acid sites; Bacteremia
资金
- Na-tional Natural Science Foundation of China [32072824, 31872505, U19A2038]
- Natural Science Foundation of Jilin Province (Changchun, China) [20200201120JC]
- Fundamental Research Funds for the Central Universities
A novel lysin, Ply1228, derived from the prophage of Streptococcus suis type 12, was found to have specific lytic activity against various S. suis strains and demonstrated therapeutic potential in a mouse model of S. suis bacteremia.
Streptococcus suis is an important zoonotic pathogen that is difficult to control with antibiotics due to the widespread development of multidrug-resistant strains. Phage lysin is considered a potential therapeutic agent to combat S. suis. In this study, the novel lysin Ply1228 derived from the prophage of S. suis type 12 was identified. Bioinformatics analysis showed that Ply1228 contains a CHAP catalytic domain, which is a binding domain composed of a CW-7 binding motif and an amidase-2 catalytic domain. The CHAP catalytic domain is essential for the bactericidal function of lysin Ply1228 and does not depend on the presence of Ca2+. C34 and H99 of the CHAP domain were identified as the key active sites. The CW-7 binding motif plays a key binding role in Ply1228. Ply1228 can specifically lyse S. suis, including types 2, 3, 7, 9, 10, 12, 14, and 27. Within 10 min, Ply1228 killed 4 log of the S. suis population, which had a starting concentration of approximately 10(7) CFU/mL. In addition, Ply1228 showed favourable thermal and pH stability. The therapeutic effect of Ply1228 was further investigated in a mouse model of S. suis bacteremia. The administration of the lysin Ply1228 (200 mu g/mouse) 1 h after the intraperitoneal injection of 2 x MLD of SS2 strain SC225 was sufficient to protect the mice (P < 0.0001) and significantly reduced the bacterial loads in the blood and organs (livers, spleens, lungs and kidneys). The levels of inflammation and histopathological damage in infected mice were effectively relieved after the Ply1228 treatment. These results indicate that Ply1228 might represent a new enzybiotic candidate for S. suis infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据